Bonjour, new guests from small-town India
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
With days to go for the roll out of Covid-19 vaccines,scientific voices are concerned about the absence of visibility on where the buck stops in the event of side-effects linked to the vaccine.
Their worry stems from clinical trial-linked incidents like the one emerging from Bhopal, where participants have allegedly said that clinical trial protocols were not followed in terms of the informed consent that needs to be taken before vaccination and medical follow-ups after it, especially if there was a reaction.
The concern is exacerbated by the fact that one of the vaccines, Covaxin, received the restricted-use approval in a ‘clinical trial mode’. The regulatory pathway becomes more unclear as some vaccine-makers seek indemnity from the government against suits linked to their Covid-19 vaccines during the pandemic period, say researchers.
The Bhopal incident involves Bharat Biotech’s vaccine Covaxin, but the hospital conducting the trial, Bhopal’s People’s College of Medical Sciences and Research Centre, denied any wrong-doing. “Volunteers were not confined to 3-4 specific communities as alleged. No gas victims were herded by us. People’s Hospital strictly abided the exclusion and inclusion criteria duly approved by the GoI (Government of India)…,” the hospital said.
Bharat Biotech and collaborator, the Indian Council of Medical Research (ICMR), did not comment on the issue. However, Suneela Thatte, Head, R&D India, IQVIA, the contract research organisation doing the trial for Bharat Biotech, told BusinessLine: “IQVIA is bound by confidentiality agreements with sponsors, and we cannot comment on any ongoing study. However, we do maintain transparency of our operations to the regulatory authorities, disclosing all necessary particulars to the regulatory authorities as required by the law and applicable regulations.”
Responding to questions on the money paid to trial participants, she saidthe company followed Indian Good Clinical Practice norms, where volunteers could be reimbursed with an amount that did not act as an inducement. “We can confirm that the same was followed in this instance, and the reimbursement amount was approved by the Institutional Ethics Committee (IEC).
On consent from participants, she saidreports suggested that the Hospital Dean had confirmed that the Informed Consent discussion was carried out with all subjects in the trial and that the site has records of the same. “Our ongoing monitoring includes periodic reviews of all study documentation to ensure all processes are in place as per the study protocol.”
Anant Bhan, a researcher on global health, bioethics and health policy, observed the incident was of concern, not only as an isolated one but also as it “goes to scale”, and the vaccine was given to many more people in the clinical trial mode. As the vaccine is given in India and other countries, the clinical trials need to be of the highest quality, he said, calling into question the role the ethics committee, ICMR, the stake-holders.
Recently, a trial volunteer on the Serum Institute (AstraZeneca-OxfordUniversity) vaccine, too, had side-effects that he said was linked to the vaccine, something the company had denied.
Commenting on the call for indemnity, Bhan said the aim should be to protect research participants and those receiving the vaccines. If the government gives indemnity, then it should take responsibility in case of an adverse event. Government representatives, though, have indicated that the responsibility lies with the manufacturer, in case of an adverse event-linked issue.
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
Citroen’s first vehicle sports a novel design and European interiors. It is also meant to be as comfortable as ...
The pandemic is only the tip of the iceberg that the country’s cash-poor airlines — both regional and national ...
The government is yet to specify the framework of its recently announced old vehicle scrappage policy
Here is a checklist that equips you to discern the market nuances
Sensex, Nifty 50 have witnessed sharp decline
The fund has consistently outperformed S&P BSE 100 TRI over one, three and five years
Returns are superior to immediate annuity plans, but SCSS can secure better rates for new investors sooner if ...
They are the health warriors who battled the Covid-19 pandemic on the ground, and are now the face of the ...
Reading in the loo — flipping through anything, really — appears to help the locomotion
Creator of the world’s biggest art canvas hopes to help children in poorer countries
A book on Badri Narayan is a tribute — albeit a belated one — to an artist who did not enjoy the recognition ...
Its name is the starting point of a brand’s journey and can make a big difference in the success sweepstakes
Sober spirits are the in thing
A peek into where ad spends went last year and where they are headed tomorrow
Can Swiggy Instamart disrupt the ecommerce groceries space, currently ruled by the Amazons and Big Baskets? ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor